PA-PMI
19.8.2020 17:02:05 CEST | Business Wire | Press release
Project Management Institute (PMI), the world's leading association for the project management profession, invites professionals across the globe to register for Virtual Experience Series titled, “The Community: Together We Rise ” on 25 August 2020 from 11 a.m. - 5 p.m. Eastern Daylight Time. The second event in this innovative series is headlined by comedian and host of The Daily Show ® program Trevor Noah, and hosted by journalist, talk show host, and executive producer, Tamron Hall. Additionally, more than 20 industry experts will lead thought-provoking sessions, including artificial intelligence thought leader and author of Girl Decoded: A Scientist’s Quest to Reclaim Our Humanity by Bringing Emotional Intelligence to Technology , Dr. Rana el Kaliouby.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200819005404/en/
The Virtual Experience Series connects participants with global innovators, inspirational voices, and project leaders to help them navigate a world defined by challenge, and embrace the opportunity to make a new reality. In the opening session, Trevor Noah will discuss how he taps into his inner project manager to galvanize a community, practice agility daily, and lead a global team. In 2015, Trevor succeeded long-time program host, Jon Stewart, and has received various accolades, including a Primetime Emmy Award win. In response to COVID-19, Trevor began hosting a modified virtual version of The Daily Show called The Daily Social Distancing Show with Trevor Noah to continue tackling the biggest stories in news, politics and pop culture. This year, The Daily Show received eight Emmy nominations.
Participants who want to boost their career or pivot to a new one can discover the Brand You Hub containing useful tips for all professionals looking to adapt and thrive in this new dynamic work environment. They can also network with project professionals in the Networking Hub and join a fireside chat with leaders of Fortune 500 organizations to explore the human side of leading during disruption, as well as lessons and takeaways from the pandemic.
“Now more than ever, PMI’s goal is to bring to the forefront insights and resources that are essential to help empower people to move projects forward and turn ideas into reality,” said Michael DePrisco, vice president, global experience & solutions at PMI. “In our post-COVID new work ecosystem, teams are putting increased emphasis on collaborative leadership and empathy to help deliver value in our virtual workplace. These are what we refer to as ‘power skills’ and PMI is here to provide the resources necessary to build and perfect these skillsets.”
Each month, the Virtual Experience Series will feature a new roster of thought-leading personalities and industry experts. Upcoming series dates and topics include:
- 9 September - A Deep Dive in Organizational Agility: Adaptability, Resilience and Learning
- 20 October - The World: Our Global Impact
- 12 November - A Deep Dive in Business Analysis: Drawing a Map to the Future
- 9 December - The Future: Forging Our Path Forward
Registration for PMI members is $99 for a single experience or $359 for the entire series. Registration for non-members is $149 for a single experience or $899 for the event series. Purchasing a series pass includes complimentary on-demand access to the PMI® Talent and Technology Symposium, which took place in June, and select recorded sessions for attendees to peruse through January 2021. Each session is eligible for professional development units (PDUs) toward maintaining PMI® certifications.
For more information on this event and to register, visit experience.pmi.org .
About Project Management Institute (PMI)
Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Through global advocacy, collaboration, education and research, we work to prepare more than three million professionals around the world for The Project Economy: the coming economy in which work, and individuals, are organized around projects, products, programs and value streams. Now 50 years in the making, we work in nearly every country around the world to advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com® website creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org , www.projectmanagement.com , www.facebook.com/PMInstitute and on Twitter @PMInstitute .
“The Daily Show” is a registered mark of Comedy Partners.
“PMI” and “Projectmanagement.com” are registered marks of Project Management Institute, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200819005404/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom